Search for: "Law360" Results 181 - 200 of 5,657
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Mar 2024, 6:17 am by Jill N. Link, Pharm.D.
*Law360 Glass Ceiling Report: What You Need To Know, Sept. 13, 2021 Jill N. [read post]
8 Mar 2024, 6:05 am by Above the Law
[Law360] * Corporate boards hate lawyers. [read post]
8 Mar 2024, 2:01 am by bklemm@foley.com
If you want to dig deeper on IP issues in innovative energy technologies, check out a recent article for Law360 by James De Vellis on IP issues in the hydrogen sector. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 10:00 pm
The Federal Trade Commission’s recent lawsuit to block Sanofi’s acquisition of a pharmaceutical treatment developed by Maze Therapeutics builds on previous enforcement actions and could indicate the agency’s growing willingness to use its so-called “killer acquisition” theory against perceived attempts to eliminate nascent competition, write partners Josh Goodman, Luisa Di Lauro, and Zachary Johns, and associate Molly Maidman. [read post]
7 Mar 2024, 6:08 am by Above the Law
[Law360] The post Morning Docket: 03.07.24 appeared first on Above the Law. [read post]
6 Mar 2024, 5:56 am by Above the Law
[Law360] * Amidst alienating return to office policies, some firms have decided to take advantage of the hybrid life to lower overhead. [read post]
5 Mar 2024, 6:05 am by Above the Law
[Law360] * The justices did a lot of reaching to get Trump back on the ballot. [read post]
4 Mar 2024, 10:00 pm by Sherica Celine
The Practical Guidance and Law360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: AI, NFTs, Cannabis, and more. [read post]
4 Mar 2024, 10:00 pm by Sherica Celine
The Practical Guidance and Law360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: NFTs, Cannabis, COVID-19, and more. [read post]
4 Mar 2024, 10:00 pm by Sherica Celine
The Practical Guidance and Law360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: NFTs, Cannabis, COVID-19, and more. [read post]
4 Mar 2024, 10:00 pm by Sherica Celine
The Practical Guidance and Law360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: NFTs, Cannabis, COVID-19, and more. [read post]
4 Mar 2024, 10:00 pm by Sherica Celine
The Practical Guidance and Law360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: NFTs, Cannabis, COVID-19, and more. [read post]
4 Mar 2024, 10:00 pm by Sherica Celine
Podcast (Anthony Oncidi) The Looming Battle over Non-compete Deals Podcast (Law360) Are You Indie or Employee? [read post]
4 Mar 2024, 10:00 pm by Sherica Celine
The Practical Guidance and Law360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: NFTs, Cannabis, COVID-19, and more. [read post]
4 Mar 2024, 10:00 pm by Sherica Celine
The Practical Guidance and Law360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: NFTs, Cannabis, COVID-19, and more. [read post]